Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids

por Francini, G, Petrioli, R, Montagnani, A, Cadirni, A, Campagna, S, Francini, E, Gonnelli, S
Publicado 2006

Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study

por Petrioli, R, Pascucci, A, Conca, R, Chiriacò, G, Francini, E, Bargagli, G, Fiaschi, A I, Manganelli, A, De Rubertis, G, Barbanti, G, Ponchietti, R, Francini, G
Publicado 2011